Form 4: VolitionRx Director Innes Acquires Shares in Registered Direct Offering
SEC Form 4
Director Guy Archibald Innes reports acquisition of VolitionRx shares through a registered direct offering and discloses beneficial ownership through various trusts.
Summary
- On March 26, 2025, Guy Archibald Innes, a director of VolitionRx Ltd, acquired 181,818 shares of common stock at a price of $0.55 per share through a registered direct offering.
- Following the transaction, Innes directly owns 868,689 shares.
- Innes also has indirect beneficial ownership of shares through The Innes Family Bare Trust 2023 (1,400,000 shares), The Dill Faulkes Educational Trust Limited (356,000 shares), and shares held by his children (154,503 or 154,504 shares each).
Sentiment
Score: 6
Explanation: Neutral sentiment. The filing simply reports a transaction. The director's purchase could be seen as a positive signal, but it's a routine disclosure.
Positives
- Director's purchase of shares may signal confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/26/2025 | Date of transaction: Acquisition of shares in registered direct offering. |
| 03/27/2025 | Date of signature for the Form 4 filing. |
Keywords
VolitionRx, Director, Share Acquisition, Beneficial Ownership, Registered Direct Offering, Form 4, Innes, VNRX
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.